Enliven Therapeutics Inc (ELVN)

Other Income/Expenses (Net)

$4.72M

Quarterly · Period ending: · USD

ELVN logo

ELVN Other Income/Expenses (Net)

Latest reported$4.72M
ELVN Quarterly Other Income/Expenses (Net) ($0.00 → $4.72M)
High-resolution chart · PNG

ELVN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
4,724,000
4,196,000
4,618,000
4,948,000
3,249,000
3,149,000
3,716,000
3,912,000
4,885,000
3,249,000
3,359,000
3,479,000
3,413,000
1,694,000
613,000
380,000
127,000
9,000
3,000
12,000
8,000
23,000
32,000
71,000
98,000
137,000
233,000
260,000
160,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.